Novo Nordisk launches oral semaglutide in India
Novo Nordisk’s diabetes drug, semaglutide, will be sold in the country in a similar price range as its injectable version.
by VICTOR EMIL KRISTENSEN, translated by daniel pedersen
On Thursday, Novo Nordisk announced that its diabetes drug semaglutide will be launched as a pill in India, as reported by media the Economic Times.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
